Vivo Capital
Xiaoyang Li, Ph.D., joined Vivo with a multidisciplinary research background focusing on medical sciences, nanotechnology and chemistry. Xiaoyang graduated with First Class Honors from Imperial College London with a B.Eng. (Bachelor of Engineering) in Materials Sciences and Engineering. She received her Ph.D. in Chemistry from Stanford University.
Her research findings were published in leading peer-reviewed journals such as Small, JCM and PNAS. Xiaoyang also completed research in the National Laboratories at Tsinghua University, Chinese Academy of Sciences, and clinical research at the Peking University People’s Hospital. Xiaoyang also completed internships with Blackstone Group as an analyst and at Cisco and FedEx with the strategic consulting team.
This person is not in the org chart
This person is not in any offices
Vivo Capital
Founded in 1996, Vivo Capital is a global investment firm focused on healthcare. Vivo has approximately $4.3 billion in assets under management, invested in over 250 public and private companies worldwide. The firm is headquartered in Palo Alto, California, with additional offices in Asia.